Sarcoma & GIST 2016 will follow a new format comprising back-to-back events
NEW Preceptorship Course/Advanced Course: 15 February 2016
Main Conference: 16-17 February 2016
The goal is to merge the clinical and the translational perspectives into a single high-profile educational event. It is a unique opportunity in rare cancers such as STS & GIST. The conference is known as an excellent place for international networking and collaboration, featuring discussions with the key opinion leaders in the field.
ESMO-MORA: The main conference programme has been accredited with 13 ESMO-MORA category 1 points. Recertification is necessary for medical oncologists to remain professionally certified by ESMO. It also guarantees that a certified medical oncologist has continued to update her/his knowledge and still possess the necessary skills and standards for the practice of medical oncology. Learn more about ESMO-MORA recertification.
CME: The ESMO Conference on Sarcoma & GIST 2016 is accredited by the European Accreditation Council for Continuing Medical Education (EACCME) to provide the following CME activity for medical specialists. The EACCME is an institution of the European Union of Medical Specialists (UEMS), uems.net The Conference programme is designated for a maximum of 12 hours of European external CME credits. Through an agreement between the European Union of Medical Specialists and the American Medical Association, physicians may convert EACCME credits to an equivalent number of AMA PRA Category 1 Credits™. Information on the process to convert EACCME credit to AMA credit can be found online here.
Webcasts from the main conference (16-17 February) will include all the session of the official programme, where speaker permission is granted, and will be available here and on OncologyPRO for ESMO Members.